All Stories

  1. Can Waves of Autoimmune Diseases Occur after the COVID-19 Pandemic?
  2. Can Vaccination with Various Types of Vaccines Make Communities Safer against COVID-19?
  3. Estimating the Size of the Hidden Population of COVID-19
  4. Important Risk Factors of Liver Cirrhosis in HIV and Hepatitis C Coinfected Patients: A Systematic Review
  5. Safety and Efficacy of Imatinib, Nilotinib, and Artesunate in COVID-19 Patients: A Systematic Review of Current Evidence
  6. The Upper-gastrointestinal Endoscopic Findings of People Living with HIV: A Systematic Review
  7. SARS-CoV-2 Infection and Severity in Patients with Hematologic Malignancies: A Systematic Review
  8. Social Avoidance and Emotional Deprivation of Healthcare Providers during the COVID-19 Pandemic
  9. The Psychological, Philosophical, and Political Implications of COVID-19
  10. Post-Exposure Prophylaxis for COVID-19: A Systematic Review
  11. Retraction statement: Evaluating the effects of air disinfectants in decontamination of COVID‐19 aerosols
  12. Retraction statement: Mucormycosisco‐infection in patients with COVID‐19: A systematic review
  13. Retraction statement: Prevalence of sexually transmitted infections and associated ‎risk behaviors in prisoners: A systematic review
  14. Retraction statement: The relationship between CRP and levels of various cytokines in patients with ‎COVID‐19: A systematic review and correlation analysis
  15. Physical and functional evaluations in oncological patients elective to medium and large operations
  16. Prevalence and complication of COVID‐19 in patients with ankylosing spondylitis (AS) and its relationship with TNF‐a inhibitors
  17. Effects of Smoking on COVID-19 Management and Mortality: An Umbrella Review
  18. Sexual and reproductive history of female prisoners in Iran: a health care needs analysis
  19. Hearing loss and COVID-19: an umbrella review
  20. Telemedicine technologies and applications in the era of COVID-19 pandemic: A systematic review
  21. The comparison of clinical, laboratory, and radiological findings in immunocompromised and immunocompetent patients with COVID‐19: A case‐control study
  22. A systematic review of sarcopenia prevalence and associated factors in people living with human immunodeficiency virus
  23. Is There a Role for Hyperbaric Oxygen Therapy in Reducing Long-Term COVID-19 Sequelae?
  24. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study
  25. Clinical and microbiological patterns in critically ill patients with catheter-associated UTI: A report from Iran
  26. Retracted: Gut microbiota and COVID‐19: A systematic review
  27. The impacts of COVID-19 pandemic on service delivery and treatment outcomes in people living with HIV: a systematic review
  28. Retracted: Evaluating the effects of air disinfectants in decontamination of COVID‐19 aerosols
  29. HIV self-testing in Iran: first implementation and feasibility study
  30. Prevalence of sexually transmitted infections (STIs) and related factors among female prisoners in Tehran, Iran
  31. Investigation of job satisfaction amongst voluntary, counseling and testing centers and health centers in Iran
  32. The relationship between cumulative dose of immunosuppressive agents and COVID‐19‐associated mucormycosis: A multicenter cross‐sectional study
  33. COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review
  34. Retracted: The relationship between C‐reactive protein and levels of various cytokines in patients with COVID‐19: A systematic review and correlation analysis
  35. Retracted: Prevalence of sexually transmitted infections and associated risk behaviors in prisoners: A systematic review
  36. Antimicrobial susceptibility testing of Staphylococcus aureus isolates from patients at a tertiary hospital in Tehran, Iran, 2018–2019
  37. Retracted: Design, development, and evaluation of a registry system for hyperbaric oxygen therapy: A methodological study
  38. Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis
  39. COVID-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice
  40. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
  41. The Value of Spiral Chest Computed Tomography Scan in the Diagnosis of Asymptomatic Coronavirus Carriers among Paranasal Sinus and Pharynx Surgery Candidates
  42. Immediate and Long-Term Effects of a Computerized Cognitive Rehabilitation Therapy on Cognitive Function in People Living with HIV in Iran: A Single-Blind Two-Arm Parallel Randomized Controlled Trial
  43. Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis
  44. Technology in the Era of COVID-19: A Systematic Review of Current Evidence
  45. Spontaneous Loculated Pneumomediastinum in a COVID-19-Infected Patient
  46. Retracted: COVID‐19 mortality and its predictors in the elderly: A systematic review
  47. The post‐Omicron situation: The end of the pandemic or a bigger challenge?
  48. Public acceptability of COVID-19 vaccines and its predictors in Middle ‎Eastern/North African (MENA) countries: a systematic review‎
  49. Mobile applications in HIV self-management: A systematic review of scientific literature
  50. COVID-19 Reinfection or Relapse? A Retrospective Multicenter Cohort Study from Iran
  51. Vaccines for COVID-19: A Systematic Review of Feasibility and Effectiveness
  52. Retracted: Internet of things in the management of chronic diseases during the COVID‐19 pandemic: A systematic review
  53. Retracted: Mucormycosis infection in patients with COVID‐19: A systematic review
  54. Retracted: Impact of COVID‐19 pandemic on routine vaccination coverage of children and adolescents: A systematic review
  55. Retracted: Prenatal and neonatal complications of COVID‐19: A systematic review
  56. Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis
  57. Combined training improves the diagnostic measures of sarcopenia and decreases the inflammation in HIV‐infected individuals
  58. Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review
  59. Comparison of the Effectiveness of Positive Thinking Group Training and Acceptance and Commitment Therapy on Psychological Well-being and Risky Behaviors of Patients with HIV
  60. Mindfulness-Based Compassion-Focused Therapy and a Comparison of Effectiveness of Stress Reduction Program on Self-Compassion of HIV Positive Patients
  61. Comparison of the effectiveness of positive thinking training and acceptance and commitment therapy on quality of life and resilience of people living with HIV
  62. Developing Aysoo: a mobile-based self-management application for people living with HIV
  63. Minimum infective dose of severe acute respiratory syndrome coronavirus 2 based on the current evidence: A systematic review
  64. Prevalence and reasons of loss to follow-up in HIV clinics: a systematic review of current evidence
  65. Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report
  66. The relationship between COVID‐19 viral load and disease severity: A systematic review
  67. COVID-19 and Alcohol Misuse: A Case Report
  68. Correction to: Predictors of the chest CT score in COVID‑19 patients: a cross‑sectional study
  69. Predictors of the chest CT score in COVID-19 patients: a cross-sectional study
  70. Mortality risk factors in kidney‐transplanted patients with COVID ‐19: A systematic review and regression analysis
  71. Identifying data elements and key features of a mobile-based self-care application for patients with COVID-19 in Iran
  72. Social Support Associated with Condom Use Behavior Among Female Sex Workers in Iran
  73. A Patient with COVID-19 Pneumonia Presenting with Plural Effusion: A Case Report
  74. COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases
  75. Postoperative COVID-19 Pneumonia in an Asymptomatic Patient: A Case Report
  76. Pulmonary Valve Endocarditis: A Case Report
  77. Transmission Modes of COVID-19: A Systematic Review
  78. Sociodemographic Characteristics, HIV-Related Risk Behaviors and HIV Prevalence of Vulnerable Men in Tehran, Iran
  79. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review
  80. Multifocal Osteolytic Lesions in Skull Bone with Mycobacterium Tuberculosis: A Case Report
  81. Security challenges and solutions using healthcare cloud computing
  82. The clinical outcomes of COVID‐19 in HIV‐positive patients: A systematic review of current evidence
  83. Distinguishing repeated polymerase chain reaction positivity from re‐infections in COVID‐19
  84. Can children of the Sputnik V vaccine recipients become symptomatic?
  85. Effects of COVID-19 prevention procedures on other common infections: a systematic review
  86. Cascade of care in people living with HIV in Iran in 2019; how far to reach UNAIDS/WHO targets
  87. Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report
  88. Bone Marrow Aspiration/Biopsy in the Evaluation of Fever of Unknown Origin in Patients with AIDS
  89. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review
  90. Genetic susceptibility of COVID-19: a systematic review of current evidence
  91. Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study
  92. NLRP3 and IL-1β Gene Expression Is Elevated in Monocytes From HIV-Treated Patients With Neurocognitive Disorders
  93. Behavioral and Clinical Characteristics and Outcomes of Treatment Among Older Patients Receiving Medical Care for HIV Infection in Iran
  94. SARS-CoV-2 Reinfection within the first 3 months of COVID-19 Recovery in A Referral Hospital, Tehran, Iran
  95. COVID-19 Re-infection or Relapse? A Retrospective Multi Center Cohort Study From Iran
  96. Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial
  97. Barriers to Antiretroviral Therapy Adherence in One of the Prisons in Iran
  98. Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison
  99. Granulomatosis with Polyangiitis (GPA) in a 15-year-old Girl with Facial Acne-like Ulcers: A Case Report
  100. Factors Associated with COVID-19 Morbidity and Mortality: A Narrative Review
  101. The Effect of First- and Second-Line Antiretroviral Therapies on Lipid Profile of HIV/AIDS Patients
  102. The prevalence and associated factors of adverse pregnancy outcomes among Afghan women in Iran; Findings from community-based survey
  103. Bacillary angiomatosis by Bartonella quintana in HIV-infected patient: molecular confirmed case in Iran
  104. Effect of green tea consumption in treatment of mild to moderate depression in Iranian patients living with HIV: A double-blind randomized clinical trial
  105. Effectiveness of mindfulness-based stress reduction training on resilience in Iranian HIV-positive women: a clinical trial
  106. Gaps and solutions of HIV testing, care, and treatment in Iran during 2018-2019
  107. HIV/HTLV-1 co-infection: a systematic review of current evidence
  108. Psychometric Properties Of Persian Version Of Patient Health Questionnaire (PHQ-9) In An Iranian HIV-Infected Patients
  109. Predictors of hospital mortality among patients with COVID-19 in Tehran, Iran
  110. Psychological symptoms of COVID-19 epidemic: A systematic review of current evidence
  111. Qualitative analysis of attitudes, behaviors, and demands of vulnerable men in Tehran, Iran
  112. Prevalence and Factors Associated with Hepatic Steatosis and Fibrosis Using Fibroscan in HIV-positive Patients Treated with Anti-retroviral (ARV) Medicines Referred to the Biggest Hospital in Tehran, 2018 to 2019
  113. The Relationships Between Early Maladaptive Schemas, Quality of Life and Self-care Behaviors in a Sample of Persons Living with HIV: The Potential Mediating Role of Cognitive Emotion Regulation Strategies
  114. Reinfection risk of novel coronavirus (CoVID-19): A systematic ‎review of current evidence
  115. Hepatitis A Seroprevalence Among Patients with Chronic Hepatitis B Infection: A Cross-Sectional Study in Iran During 2016-2017
  116. Determinants of Needle Stick Injuries Among Healthcare Providers at a Tehran University Hospital in 2016: A Descriptive Report
  117. The Relationship Between HIV Antibody Titer, HIV Viral Load, HIV p24 Antigen, and CD4 T-cell Count Among Iranian HIV-positive Patients
  118. Predictors of mortality in patients with COVID-19–a systematic review
  119. Combination of resistance and aerobic exercise for six months improves bone mass and physical function in HIV infected individuals: A randomized controlled trial
  120. HIV in Iran: onset, responses, and future directions
  121. The relationship between social roles and psychosocial adjustment in women with HIV: A structural equation model
  122. A systematic review of ECG findings in patients with COVID-19
  123. Prevalence of Cancers Among Patients with HIV Referring to Voluntary Counseling and Testing Center, Tehran, Iran, 2004-2017
  124. Efficacy and Safety of Arbidol in Treatment of Patients with COVID-19 Infection: A Randomized Clinical Trial
  125. Prevalence of COVID-19-like Symptoms among People Living with HIV, and Using Antiretroviral Therapy for Prevention and Treatment
  126. A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case
  127. Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
  128. Epidemiology of HIV in Iran
  129. A mobile-based self-management application- usability evaluation from the perspective of HIV-positive people
  130. A study of barriers to adherence of antiretroviral treatment in prisoners living with HIV in Tehran, Iran
  131. The prevalence and associated factors of adverse pregnancy outcomes among Afghan women in Iran; the possible impacts of domestic violence, poor mental health, housing issues, and food security
  132. Superior Mesenteric Venous (SMV) Thrombosis Accompanied with Appendicitis in a Patient with Primary Diagnosis of Typhoid Fever
  133. Barriers and associated factors for adequate antenatal care among Afghan women in Iran; findings from a community-based survey
  134. Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital
  135. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence
  136. EFFECT OF AEROBIC EXERCISE ON FLAT, DOWNHILL, AND UPHILL LEVEL ON SERUM LEVELS OF LEPTIN AND ADIPONECTIN IN CHRONIC OBSTRUVTIVE PULMINARY DISEASE PATIENTS
  137. Disseminated TB in an Immunocompetent Patient: A Case Report
  138. HIV and Risk Behaviors Among Visitors of Inmates at the Great Tehran Prison, Iran, 2018
  139. “It is good, but I can’t afford it …” potential barriers to adequate prenatal care among Afghan women in Iran: a qualitative study in South Tehran
  140. Health service provision for disease control among prisoners: a conceptual note
  141. Brucella Pneumonia with Systemic Complications and Pancytopenia: A Case Report
  142. Comparison of tuberculosis indicators after implementation of the clinical protocol for tuberculosis and HIV management in Iranian prisons: a quasi-experimental study
  143. Lung Involvement Found on Chest CT Scan in a Pre-Symptomatic Person with SARS-CoV-2 Infection: A Case Report
  144. Determinants and barriers of adequate antenatal care among Afghan women in Iran; findings from a community-based survey in Iran
  145. Self-Care Instructions for People Not Requiring Hospitalization for Coronavirus Disease 2019 (COVID-19)
  146. The relationship between social roles and psychosocial adjustment in women with AIDS: A structural equation model
  147. “It is good, but I can’t afford it…” potential barriers to adequate prenatal care among Afghan women in Iran: a qualitative study in south Tehran
  148. Prospective and Retrospective Memory Complaints in HIV-Infected Individuals
  149. Isolated severe thrombocytopenia in a patient with COVID-19: A case report
  150. Prevalence of HIV-associated neurocognitive disorder (HAND) and its subgroups among HIV-positive persons on anti-retroviral therapy in Iran
  151. Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19)
  152. Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran
  153. Effect of probiotic consumption on increasing the CD4+ T cell counts among Iranian patients living with HIV
  154. Green formulation of curcumin loaded lipid-based nanoparticles as a novel carrier for inhibition of post-angioplasty restenosis
  155. Virologic Failure in Different Antiretroviral Regimens Among Pediatric Patients with HIV Referring to a Voluntary Counseling and Testing (VCT) Center in Tehran, Iran (2004 - 2017)
  156. The HIV treatment cascade in people living with HIV in Iran in 2014: Mixed-method study to measure losses and reasons
  157. Content Analysis of Teleconsultation Enquiries in Positive Health Club, Imam Khomeini Hospital, Tehran, Iran
  158. Effect of a Short-term Lifestyle Modification Program on Quality of Life, Anthropometric Characteristics and CD4+T Cell Count of HIV Infected Patients in Tehran/Iran: A Randomized Controlled Trial
  159. Effect of 8 Weeks of Hospital-Based Resistance Training Program on TCD4+ Cell Count and Anthropometric Characteristic of Patients With HIV in Tehran, Iran: A Randomized Controlled Trial
  160. Effects of Aerobic Dance Training on Psychological Well-Being and Immune Function of Women Living With HIV
  161. National Commitments and Policy Instrument
  162. Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients
  163. Association Between Immunologic and Virologic Functioning and Health-Related Quality of Life Among People Living with HIV, Tehran, Iran
  164. An Estimation of HIV/AIDS’s Cost in the Voluntary Counseling and Testing Center of Imam Khomeini Hospital in 2010-2011
  165. Preclinical and Clinical Safety and Efficacy of Faramir Treatment: A Novel Anti-Retroviral Drug
  166. Exploring and prioritization of mobile-based self-management strategies for HIV care
  167. HIV Prevalence and Correlations in Prisons in Different Regions of the World: A Review Article
  168. Different Degrees of Immune Recovery Using Antiretroviral Regimens with Vonavir or Zidovudine/Lamivudine/Efavirenz in HIVPositive Patients Receiving First Line Treatment in Iran
  169. Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus among HIV Positive Patients in Tehran, Iran
  170. Pseudomonas Aeruginosa Osteomyelitis of the Pubic Bone: A Case Report
  171. Prevalence of Tuberculosis in a Prison in Tehran by Active Case Finding
  172. Barriers to Adherence to Antiretroviral Treatment Among Inmates of a Prison in Tehran, Iran: A Qualitative Study
  173. Common elements and features of a mobile-based self-management system for people living with HIV
  174. Comparing Tuberculosis Incidence in a Prison with the Society, Tehran, Iran
  175. John Cunningham virus large T antigen detection in brain biopsy of an HIV-infected patient with glioblastoma multiforme
  176. Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation
  177. Evaluation of Acquired HIV Drug Resistance among People Living with HIV Who Have Taken Antiretroviral Therapy for 9–15 Months in 14 Triangular Clinics in Iran, 2015–2016
  178. Prevalence of Adverse Drug Reactions to Highly Active Antiretroviral Therapy (HAART) among HIV Positive Patients in Imam Khomeini Hospital of Tehran, Iran
  179. Revision and Implementation of “Clinical Guideline for Tuberculosis and HIV in Prisons”, Great Tehran Prison, Iran
  180. Evaluation of Echocardiographic Abnormalities in HIV Positive Patients Treated with Antiretroviral Medications
  181. Zika virus: A review of literature
  182. Adherence to Antiretroviral Therapy and Tuberculosis Treatment in a Prison of Tehran, Iran
  183. Frontiers in HIV Research
  184. Integration of HIV Services into Primary Health Care (PHC) System
  185. Demographic, Clinical and Laboratory Profiles of HIV Infected Patients Admitted into Imam Khomeini Hospital of Tehran, Iran
  186. Quickness of HIV and Tuberculosis Diagnostic Procedures in Prison of Tehran, Iran
  187. HIV-related risk behaviors among male inmates of Tehran, Iran
  188. Tuberculosis, hepatitis C and hepatitis B co-infections in patients with HIV in the Great Tehran Prison, Iran
  189. Impulsivity, Sensation Seeking, and Risk-Taking Behaviors among HIV-Positive and HIV-Negative Heroin Dependent Persons
  190. A follow-up program after prison release for HIV-positive patients
  191. “Evaluation of the Association between Addiction Severity Index and Depression with Adherence to Anti-retroviral Therapy among HIV Infected Patients”
  192. Perceived social support affects disease coping among people living with HIV: a study in Tehran, Iran
  193. Ebola viral disease: a review literature
  194. A new method to study knowledge, attitude and practice regarding HIV/AIDS in Iranian general population
  195. Psychological, social, and familial problems of people living with HIV/AIDS in Iran: A qualitative study
  196. Early initiation of antiretroviral treatment: Challenges in the Middle East and North Africa
  197. Problems of providing services to people affected by HIV/AIDS: service providers and recipients perspectives
  198. Addressing predictors of HIV related risk behaviors: Demographic and psychosocial profile of Iranian patients
  199. Subtype Classification of Iranian HIV-1 Sequences Registered in the HIV Databases, 2006-2013
  200. A study of the knowledge on HIV in regards to routes of transmission and sexual practices in men between the ages of 20 to 50 in Tehran
  201. Antiretroviral drug resistance among antiretroviral-naïve and treatment experienced patients infected with HIV in Iran
  202. Mechanisms of Anti-retroviral Drug Resistance: Implications for Novel Drug Discovery and Development
  203. The effects of a social-cognitive method based education on knowledge and attitudes intentions with respect to HIV transmition among school learners in Maragheh, Iran
  204. Neurological manifestations in HIV positive patients in Tehran, Iran
  205. Impact of Age on CD4 Response to Combination Antiretroviral Therapy: A Study in Tehran, Iran
  206. Prevalence of HIV infection and the correlates among homeless in Tehran, Iran
  207. The effectiveness of discharge planning on the knowledge, clinical symptoms and hospitalisation frequency of persons with schizophrenia: a longitudinal study in two hospitals in Tehran, Iran
  208. Evaluation of Stigma Index Among People Living With HIV/AIDS (PLWHA) in Six Cities in Iran
  209. The emergence of drug resistant HIV variants and novel anti–retroviral therapy
  210. Post Marketing Surveillance on Safety and Efficacy of IMOD in Iranian Patients with HIV/AIDS
  211. Prevalence survey of infection with Treponema pallidum among HIV-positive patients in Tehran
  212. Prevalence of HIV infection and the correlates among beggars in Tehran, Iran
  213. Emerging HIV Drug Resistance in the Resource-Poor World: Challenges and Strategies
  214. Rheumatologic Manifestations Among HIV-positive Patients, Tehran, Iran
  215. Adherence to Anti-Retroviral Therapy and Its Determinants in HIV/AIDS Patients: A Review
  216. Tetanus in an unvaccinated child: A case report
  217. Prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infections among HIV infected people in Irans
  218. Adherence to Antiretroviral Therapy Among Iranian HIV/AIDS Patients
  219. Safety and Efficacy of Setarud (IMOD TM ) Among People Living with HIV/AIDS: A Review
  220. Prevalence of dermatologic manifestations among people living with HIV/AIDS in Imam Khomeini Hospital in Tehran, Iran
  221. Treatment with IMODTM as a Novel Immune Modulator in HIV Positive Patients
  222. Quality of Life among Persons with HIV/AIDS in Iran: Internal Reliability and Validity of an International Instrument and Associated Factors
  223. Randomized Controlled Trial of Mindfulness-Based Stress Reduction Delivered to Human Immunodeficiency Virus–Positive Patients in Iran
  224. Otolaryngological Manifestations in HIV Infected Patients, Tehran, Iran
  225. Post Marketing Surveillance on Safety and Efficacy of IMOD in Iranian Patients with HIV/AIDS
  226. Frequency of HIV Infection among Sailors in South of Iran by Rapid HIV Test
  227. Incidence of Mongolian Spots and its Common Sites at Two University Hospitals in Tehran, Iran
  228. Environmental risk factors for lung cancer in Iran: a case-control study
  229. Prevalence and Correlates of HIV Infection Among Male Injection Drug Users in Detention in Tehran, Iran
  230. Prevalence and Correlates of Hepatitis C Infection among Male Injection Drug Users in Detention, Tehran, Iran
  231. Environmental risk factors for lung cancer in Iran: a case-control study
  232. Vitiligo in a patient associated with human immunodeficiency virus infection and repigmentation under antiretroviral therapy
  233. HIV seroconversion among injection drug users in detention, Tehran, Iran
  234. Hirsutism
  235. Erectile Dysfunction in Diabetic Patients
  236. Novel Vascular Molecule Involved in Monocyte Adhesion to Aortic Endothelium in Models of Atherogenesis
  237. Arch Microbiology